Late-life Hemoglobin and the Incidence of Parkinson's Disease

Overview

Journal Neurobiol Aging

Publisher Elsevier

Specialties Geriatrics
Neurology
Physiology

Date 2010 Aug 17

PMID 20709430

Citations 19

Authors

Robert D Abbott

G Webster Ross

Caroline M Tanner

Julie K Andersen

Kamal H Masaki

Beatriz L Rodriguez

Lon R White

Helen Petrovitch

Affiliations

Soon will be listed here.

Abstract

Brain iron promotes neurodegeneration in Parkinson's disease (PD). While hemoglobin (Hb) is the most abundant source of peripheral iron in humans, its relationship with PD is uncertain. This report examines the association between Hb in late life and PD incidence. From 1991 to 1993, Hb was measured in 3507 men in the Honolulu-Asia Aging Study. Men were aged 71-93 years and without PD. Participants were followed until 2001 for incident PD. Hb levels declined markedly with age. For men aged 71-75 years, 14.8% had levels < 14 g/dL versus 53.6% in those aged 86 and older (p < 0.001). During follow-up, 47 men developed PD (19.8/10,000 person-years). After age adjustment, PD incidence rose significantly from 10.3 to 34.9/10,000 person-years as Hb increased from < 14 to ≥ 16 g/dL (p = 0.024; relative hazard 3.2; 95% confidence interval, 1.2-8.9). Associations persisted after accounting for early mortality and adjustments for concomitant risk factors. While Hb declines with advancing age, evidence suggests that Hb that remains high in elderly men is associated with an increased risk of PD.

Citing Articles

Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer's and Parkinson Disease.

Campomayor N, Kim H, Kim M Biomol Ther (Seoul). 2025; 33(2):235-248.

PMID: 39962769 PMC: 11893490. DOI: 10.4062/biomolther.2024.224.

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.

Kuang Y, Mao H, Huang X, Chen M, Dai W, Gan T Transl Neurodegener. 2024; 13(1):56.

PMID: 39574205 PMC: 11580393. DOI: 10.1186/s40035-024-00449-2.

Bioinformatics gene analysis for potential biomarkers and therapeutic targets of Parkinson's disease based on neutrophil extracellular traps.

Wang Q, Gu Y, Chen J, Liu X, Xie C, Wang X Front Aging Neurosci. 2024; 16:1388226.

PMID: 38882525 PMC: 11178047. DOI: 10.3389/fnagi.2024.1388226.

Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study.

He L, Zhou Q, Xiu C, Shao Y, Shen D, Meng H Neural Regen Res. 2023; 19(8):1842-1848.

PMID: 38103252 PMC: 10960292. DOI: 10.4103/1673-5374.389357.

The shared genetic landscape of blood cell traits and risk of neurological and psychiatric disorders.

Yang Y, Zhou Y, Nyholt D, Yap C, Tannenberg R, Wang Y Cell Genom. 2023; 3(2):100249.

PMID: 36819664 PMC: 9932996. DOI: 10.1016/j.xgen.2022.100249.

References

Ferrucci L, Guralnik J, Bandinelli S, Semba R, Lauretani F, Corsi A . Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol. 2007; 136(6):849-55. PMC: 2669300. DOI: 10.1111/j.1365-2141.2007.06502.x. View

Ross G, Abbott R, Petrovitch H, Morens D, Grandinetti A, Tung K . Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000; 283(20):2674-9. DOI: 10.1001/jama.283.20.2674. View

Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, Lojacono N . Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord. 1998; 13 Suppl 1:13-6. View

Wolozin B, Golts N . Iron and Parkinson's disease. Neuroscientist. 2002; 8(1):22-32. DOI: 10.1177/107385840200800107. View

Powers K, Smith-Weller T, Franklin G, Longstreth Jr W, Swanson P, Checkoway H . Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003; 60(11):1761-6. DOI: 10.1212/01.wnl.0000068021.13945.7f. View

Bartzokis G, Tishler T, Lu P, Villablanca P, Altshuler L, Carter M . Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging. 2006; 28(3):414-23. DOI: 10.1016/j.neurobiolaging.2006.02.005. View

Chinta S, Kumar M, Hsu M, Rajagopalan S, Kaur D, Rane A . Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci. 2007; 27(51):13997-4006. PMC: 6673525. DOI: 10.1523/JNEUROSCI.3885-07.2007. View

Morens D, Davis J, Grandinetti A, Ross G, Popper J, White L . Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology. 1996; 46(4):1044-50. DOI: 10.1212/wnl.46.4.1044. View

Mehta C, Patel N . Exact logistic regression: theory and examples. Stat Med. 1995; 14(19):2143-60. DOI: 10.1002/sim.4780141908. View

10.

HALLGREN B, SOURANDER P . The effect of age on the non-haemin iron in the human brain. J Neurochem. 1958; 3(1):41-51. DOI: 10.1111/j.1471-4159.1958.tb12607.x. View

11.

Logroscino G, Gao X, Chen H, Wing A, Ascherio A . Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol. 2008; 168(12):1381-8. PMC: 2727188. DOI: 10.1093/aje/kwn273. View

12.

Ross G, Petrovitch H, Abbott R, Nelson J, Markesbery W, Davis D . Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004; 56(4):532-9. DOI: 10.1002/ana.20226. View

13.

Haaxma C, Bloem B, Borm G, Oyen W, Leenders K, Eshuis S . Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006; 78(8):819-24. PMC: 2117736. DOI: 10.1136/jnnp.2006.103788. View

14.

Abbott R, Petrovitch H, White L, Masaki K, Tanner C, Curb J . Frequency of bowel movements and the future risk of Parkinson's disease. Neurology. 2001; 57(3):456-62. DOI: 10.1212/wnl.57.3.456. View

15.

Rhodes S, Ritz B . Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis. 2008; 32(2):183-95. PMC: 3643980. DOI: 10.1016/j.nbd.2008.07.001. View

16.

Abbott R, Ross G, White L, Tanner C, Masaki K, Nelson J . Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005; 65(9):1442-6. DOI: 10.1212/01.wnl.0000183056.89590.0d. View

17.

Beard J, Connor J . Iron status and neural functioning. Annu Rev Nutr. 2003; 23:41-58. DOI: 10.1146/annurev.nutr.23.020102.075739. View

18.

Kaur D, Andersen J . Does cellular iron dysregulation play a causative role in Parkinson's disease?. Ageing Res Rev. 2004; 3(3):327-43. DOI: 10.1016/j.arr.2004.01.003. View

19.

Lane P, Nelder J . Analysis of covariance and standardization as instances of prediction. Biometrics. 1982; 38(3):613-21. View

20.

Cammack R, Shergill J, Ananda Inalsingh V, Hughes M . Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide. Spectrochim Acta A Mol Biomol Spectrosc. 1999; 54A(14):2393-402. DOI: 10.1016/s1386-1425(98)00219-4. View